PAG
GMAB icon

Private Advisor Group’s Genmab GMAB Stock Holding History

Private Advisor Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,522
Closed -$666K – 2003
2022
Q2 		$666K Buy
20,522
+403
+2% +$13.1K 0.01% 1260
2022
Q1 		$728K Buy
20,119
+3,891
+24% +$134K 0.01% 1238
2021
Q4 		$642K Sell
16,228
-12,907
-44% -$538K ﹤0.01% 1327
2021
Q3 		$1.27M Buy
29,135
+14,990
+106% +$673K 0.01% 1089
2021
Q2 		$577K Buy
14,145
+1,207
+9% +$46.6K 0.01% 1321
2021
Q1 		$425K Sell
12,938
-1,862
-13% -$70K ﹤0.01% 1384
2020
Q4 		$602K Buy
14,800
+3,431
+30% +$128K 0.01% 1128
2020
Q3 		$399K Buy
11,369
+546
+5% +$19.7K 0.01% 1152
2020
Q2 		$367K Buy
+10,823
New +$295K 0.01% 1137

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Private Advisor Group's GMAB Position: Q3 2022 in Review

Private Advisor Group sold out of Genmab (GMAB) in Q3 2022, closing a stake of 20,522 shares — an estimated $666K sold.

Private Advisor Group first reported a position in GMAB in Q2 2020 and held it in 9 quarters. The position peaked at $1.27M in Q3 2021. 193 funds tracked by Wall St. Rank hold GMAB as of Q3 2022.

  • Private Advisor Group reported no remaining Genmab position as of Q3 2022 after selling out during the quarter.
  • Private Advisor Group sold 20,522 Genmab shares in Q3 2022, an estimated $666K.
  • Private Advisor Group first reported a position in Genmab in Q2 2020 and held it in 9 quarters.
  • Private Advisor Group's Genmab position peaked at $1.27M in Q3 2021.
  • 193 funds tracked by Wall St. Rank held Genmab as of Q3 2022.

Based on Private Advisor Group's 13F filing for Q3 2022, filed 14 Oct 2022.